Skip to main content
Top
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Research article

Healthcare utilisation in general practice and hospitals in the year preceding a diagnosis of cancer recurrence or second primary cancer: a population-based register study

Authors: Linda Aagaard Rasmussen, Henry Jensen, Line Flytkjær Virgilsen, Alina Zalounina Falborg, Henrik Møller, Peter Vedsted

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

The organisation of cancer follow-up is under scrutiny in many countries, and general practice is suggested to become more involved. A central focus is timely detection of recurring previous cancer and new second primary cancer. More knowledge on the patient pathway before cancer recurrence and second primary cancer is warranted to ensure the best possible organisation of follow-up. We aimed to describe the healthcare utilisation in the year preceding a diagnosis of cancer recurrence or second primary cancer.

Methods

This nationwide register study comprises patients diagnosed with bladder, breast, colorectal, endometrial, lung, malignant melanoma and ovarian cancer in Denmark in 2008–2016. The frequency of healthcare contacts during the 12 months preceding a cancer recurrence or second primary cancer was estimated and compared to the frequency of cancer survivors in cancer remission. The main analyses were stratified on sex and healthcare setting. Furthermore, two sub-analyses were stratified on 1) sex, healthcare setting and age group and on 2) sex, healthcare setting and comorbidity status.

Results

The study population consisted of 7832 patients with recurrence and 2703 patients with second primary cancer. On average, the patients were in contact with general practice one time per month in the 12th month preceding a new cancer diagnosis (recurrence or second primary cancer). Increasing contact rates were seen from 7 months before diagnosis in general practice and from 12 months before diagnosis in hospitals. This pattern was more pronounced in patients with cancer recurrence, younger patients and patients with no comorbidity. For instance, the contact rate ratios for hospital contacts in non-comorbid women with recurrence demonstrated 30% more contacts in the 12th month before recurrence and 127% more contacts in the 2nd month before recurrence.

Conclusions

The results show that cancer survivors are already seen in general practice on a regular basis. The increasing contact rates before a diagnosis of cancer recurrence or second primary cancer indicate that a window of opportunity exists for more timely diagnosis; this is seen in both general practice and in hospitals. Thus, cancer survivors may benefit from improvements in the organisation of cancer follow-up.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16(12):1231–72.CrossRefPubMed Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16(12):1231–72.CrossRefPubMed
2.
go back to reference Ignatov A, Eggemann H, Burger E, Ignatov T. Patterns of breast cancer relapse in accordance to biological subtype. J Cancer Res Clin Oncol. 2018;144(7):1347–55.CrossRefPubMed Ignatov A, Eggemann H, Burger E, Ignatov T. Patterns of breast cancer relapse in accordance to biological subtype. J Cancer Res Clin Oncol. 2018;144(7):1347–55.CrossRefPubMed
3.
go back to reference Wille-Jorgensen P, Syk I, Smedh K, Laurberg S, Nielsen DT, Petersen SH, et al. Effect of more vs less frequent follow-up testing on overall and colorectal cancer-specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial. JAMA. 2018;319(20):2095–103.CrossRefPubMedPubMedCentral Wille-Jorgensen P, Syk I, Smedh K, Laurberg S, Nielsen DT, Petersen SH, et al. Effect of more vs less frequent follow-up testing on overall and colorectal cancer-specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial. JAMA. 2018;319(20):2095–103.CrossRefPubMedPubMedCentral
4.
go back to reference Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller D. Detecting lung and colorectal cancer recurrence using structured clinical/administrative data to enable outcomes research and population health management. Med Care. 2017;55(12):e88–98.CrossRefPubMedPubMedCentral Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller D. Detecting lung and colorectal cancer recurrence using structured clinical/administrative data to enable outcomes research and population health management. Med Care. 2017;55(12):e88–98.CrossRefPubMedPubMedCentral
5.
go back to reference Zattoni F, Morlacco A, Nehra A, Frank I, Boorjian SA, Thapa P, et al. Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse. Int Braz J Urol. 2018;44(3):491–9.CrossRefPubMedPubMedCentral Zattoni F, Morlacco A, Nehra A, Frank I, Boorjian SA, Thapa P, et al. Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse. Int Braz J Urol. 2018;44(3):491–9.CrossRefPubMedPubMedCentral
6.
go back to reference Soerjomataram I, Coebergh JW. Epidemiology of multiple primary cancers. Methods Mol Biol. 2009;471:85–105.CrossRefPubMed Soerjomataram I, Coebergh JW. Epidemiology of multiple primary cancers. Methods Mol Biol. 2009;471:85–105.CrossRefPubMed
7.
go back to reference Gelli M, Huguenin JFL, de Baere T, Benhaim L, Mariani A, Boige V, et al. Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: what survival can we expect? Eur J Cancer. 2018;100:94–103.CrossRefPubMed Gelli M, Huguenin JFL, de Baere T, Benhaim L, Mariani A, Boige V, et al. Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: what survival can we expect? Eur J Cancer. 2018;100:94–103.CrossRefPubMed
8.
go back to reference Taylor JM, Spiess PE, Kassouf W, Munsell MF, Kamat AM, Dinney CP, et al. Management of urethral recurrence after orthotopic urinary diversion. BJU Int. 2010;106(1):56–61.CrossRefPubMed Taylor JM, Spiess PE, Kassouf W, Munsell MF, Kamat AM, Dinney CP, et al. Management of urethral recurrence after orthotopic urinary diversion. BJU Int. 2010;106(1):56–61.CrossRefPubMed
9.
go back to reference Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS, et al. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax. 2009;64(3):192–6.CrossRefPubMed Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS, et al. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax. 2009;64(3):192–6.CrossRefPubMed
10.
go back to reference Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112(Suppl 1):S92–107.CrossRefPubMedPubMedCentral Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112(Suppl 1):S92–107.CrossRefPubMedPubMedCentral
11.
go back to reference Torring ML, Murchie P, Hamilton W, Vedsted P, Esteva M, Lautrup M, et al. Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries. Br J Cancer. 2017;117(6):888–97.CrossRefPubMedPubMedCentral Torring ML, Murchie P, Hamilton W, Vedsted P, Esteva M, Lautrup M, et al. Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries. Br J Cancer. 2017;117(6):888–97.CrossRefPubMedPubMedCentral
12.
go back to reference Nekhlyudov L, O'malley DM, Hudson SV. Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities. Lancet Oncol. 2017;18(1):e30–8.CrossRefPubMedPubMedCentral Nekhlyudov L, O'malley DM, Hudson SV. Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities. Lancet Oncol. 2017;18(1):e30–8.CrossRefPubMedPubMedCentral
13.
go back to reference McCabe MS, Partridge AH, Grunfeld E, Hudson MM. Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol. 2013;40(6):804–12.CrossRefPubMedPubMedCentral McCabe MS, Partridge AH, Grunfeld E, Hudson MM. Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol. 2013;40(6):804–12.CrossRefPubMedPubMedCentral
14.
go back to reference Meiklejohn JA, Mimery A, Martin JH, Bailie R, Garvey G, Walpole ET, et al. The role of the GP in follow-up cancer care: a systematic literature review. J Cancer Surviv. 2016;10(6):990–1011.CrossRefPubMed Meiklejohn JA, Mimery A, Martin JH, Bailie R, Garvey G, Walpole ET, et al. The role of the GP in follow-up cancer care: a systematic literature review. J Cancer Surviv. 2016;10(6):990–1011.CrossRefPubMed
15.
go back to reference Lewis RA, Neal RD, Hendry M, France B, Williams NH, Russell D, et al. Patients’ and healthcare professionals' views of cancer follow-up: systematic review. Br J Gen Pract. 2009;59(564):e248–59.CrossRefPubMedPubMedCentral Lewis RA, Neal RD, Hendry M, France B, Williams NH, Russell D, et al. Patients’ and healthcare professionals' views of cancer follow-up: systematic review. Br J Gen Pract. 2009;59(564):e248–59.CrossRefPubMedPubMedCentral
16.
go back to reference Lewis RA, Neal RD, Williams NH, France B, Hendry M, Russell D, et al. Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract. 2009;59(564):e234–47.CrossRefPubMedPubMedCentral Lewis RA, Neal RD, Williams NH, France B, Hendry M, Russell D, et al. Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract. 2009;59(564):e234–47.CrossRefPubMedPubMedCentral
17.
go back to reference Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, et al. Routine follow up of breast cancer in primary care: randomised trial. BMJ. 1996;313(7058):665–9.CrossRefPubMedPubMedCentral Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, et al. Routine follow up of breast cancer in primary care: randomised trial. BMJ. 1996;313(7058):665–9.CrossRefPubMedPubMedCentral
18.
go back to reference Christensen NL, Dalton SO, Mellemgaard A, Christensen J, Kejs AMT, Rasmussen TR. Assessing the pattern of recurrence in Danish stage I lung cancer patients in relation to the follow-up program: are we failing to identify patients with cerebral recurrence? Acta Oncol. 2018;57(11):1556–60.CrossRefPubMed Christensen NL, Dalton SO, Mellemgaard A, Christensen J, Kejs AMT, Rasmussen TR. Assessing the pattern of recurrence in Danish stage I lung cancer patients in relation to the follow-up program: are we failing to identify patients with cerebral recurrence? Acta Oncol. 2018;57(11):1556–60.CrossRefPubMed
19.
go back to reference Duineveld LA, van Asselt KM, Bemelman WA, Smits AB, Tanis PJ, van Weert HC, et al. Symptomatic and asymptomatic colon cancer recurrence: a multicenter cohort study. Ann Fam Med. 2016;14(3):215–20.CrossRefPubMedPubMedCentral Duineveld LA, van Asselt KM, Bemelman WA, Smits AB, Tanis PJ, van Weert HC, et al. Symptomatic and asymptomatic colon cancer recurrence: a multicenter cohort study. Ann Fam Med. 2016;14(3):215–20.CrossRefPubMedPubMedCentral
20.
go back to reference Brandenbarg D, Berendsen AJ, de Bock GH. Patients’ expectations and preferences regarding cancer follow-up care. Maturitas. 2017;105:58–63.CrossRefPubMed Brandenbarg D, Berendsen AJ, de Bock GH. Patients’ expectations and preferences regarding cancer follow-up care. Maturitas. 2017;105:58–63.CrossRefPubMed
21.
go back to reference Christensen KG, Fenger-Gron M, Flarup KR, Vedsted P. Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis - a population-based nationwide registry study of 127,000 incident adult cancer patients. BMC Health Serv Res. 2012;12:224.CrossRefPubMedPubMedCentral Christensen KG, Fenger-Gron M, Flarup KR, Vedsted P. Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis - a population-based nationwide registry study of 127,000 incident adult cancer patients. BMC Health Serv Res. 2012;12:224.CrossRefPubMedPubMedCentral
22.
go back to reference Hansen PL, Hjertholm P, Vedsted P. Increased diagnostic activity in general practice during the year preceding colorectal cancer diagnosis. Int J Cancer. 2015;137(3):615–24.CrossRefPubMed Hansen PL, Hjertholm P, Vedsted P. Increased diagnostic activity in general practice during the year preceding colorectal cancer diagnosis. Int J Cancer. 2015;137(3):615–24.CrossRefPubMed
23.
go back to reference Augestad KM, Norum J, Rose J, Lindsetmo R-O. A prospective analysis of false positive events in a national Colon Cancer surveillance program. BMC Health Serv Res. 2014;14(1):137.CrossRefPubMedPubMedCentral Augestad KM, Norum J, Rose J, Lindsetmo R-O. A prospective analysis of false positive events in a national Colon Cancer surveillance program. BMC Health Serv Res. 2014;14(1):137.CrossRefPubMedPubMedCentral
24.
go back to reference Pedersen KM, Andersen JS, Søndergaard J. General practice and primary health care in Denmark. J Am Board Fam Med. 2012;25(Suppl 1):34–8.CrossRef Pedersen KM, Andersen JS, Søndergaard J. General practice and primary health care in Denmark. J Am Board Fam Med. 2012;25(Suppl 1):34–8.CrossRef
25.
26.
go back to reference Lash TL, Riis AH, Ostenfeld EB, Erichsen R, Vyberg M, Thorlacius-Ussing O. A validated algorithm to ascertain colorectal cancer recurrence using registry resources in Denmark. Int J Cancer. 2015;136(9):2210–5.CrossRefPubMed Lash TL, Riis AH, Ostenfeld EB, Erichsen R, Vyberg M, Thorlacius-Ussing O. A validated algorithm to ascertain colorectal cancer recurrence using registry resources in Denmark. Int J Cancer. 2015;136(9):2210–5.CrossRefPubMed
27.
go back to reference Rasmussen LA, Jensen H, Virgilsen LF, Jensen JB, Vedsted P. A validated algorithm to identify recurrence of bladder cancer: a register-based study in Denmark. Clin Epidemiol. 2018;10:1755–63.CrossRefPubMedPubMedCentral Rasmussen LA, Jensen H, Virgilsen LF, Jensen JB, Vedsted P. A validated algorithm to identify recurrence of bladder cancer: a register-based study in Denmark. Clin Epidemiol. 2018;10:1755–63.CrossRefPubMedPubMedCentral
28.
go back to reference Rasmussen LA, Jensen H, Virgilsen LF, Thorsen LBJ, Offersen BV, Vedsted P. A validated algorithm for register-based identification of patients with recurrence of breast cancer in Denmark – based on Danish Breast Cancer Group (DBCG) data. Cancer Epidemiol. 2019;59:129–34.CrossRef Rasmussen LA, Jensen H, Virgilsen LF, Thorsen LBJ, Offersen BV, Vedsted P. A validated algorithm for register-based identification of patients with recurrence of breast cancer in Denmark – based on Danish Breast Cancer Group (DBCG) data. Cancer Epidemiol. 2019;59:129–34.CrossRef
29.
go back to reference Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45(1):255–68.CrossRefPubMed Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45(1):255–68.CrossRefPubMed
30.
go back to reference McBride GB. A proposal for strength of agreement criteria for Lin's concordance correlation coefficient. Hamilton: National Institute of Water & Atmospheric Research; 2005. McBride GB. A proposal for strength of agreement criteria for Lin's concordance correlation coefficient. Hamilton: National Institute of Water & Atmospheric Research; 2005.
31.
go back to reference Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82.CrossRefPubMed Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82.CrossRefPubMed
32.
go back to reference Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–90.CrossRefPubMedPubMedCentral Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–90.CrossRefPubMedPubMedCentral
33.
go back to reference Andersen JS, Olivarius Nde F, Krasnik A. The Danish National Health Service Register. Scand J Public Health. 2011;39(7 Suppl):34–7.CrossRefPubMed Andersen JS, Olivarius Nde F, Krasnik A. The Danish National Health Service Register. Scand J Public Health. 2011;39(7 Suppl):34–7.CrossRefPubMed
35.
go back to reference UNESCO Institute for Statistics. International standard classification of education ISCED 2011. Montreal: UNESCO Institute for Statistics; 2012. 88 p.CrossRef UNESCO Institute for Statistics. International standard classification of education ISCED 2011. Montreal: UNESCO Institute for Statistics; 2012. 88 p.CrossRef
36.
go back to reference Statistics Denmark. Uddannelsesstatistikkens manual [Manual of educational statistics]. Copenhagen: Statistics Denmark; 2016. Statistics Denmark. Uddannelsesstatistikkens manual [Manual of educational statistics]. Copenhagen: Statistics Denmark; 2016.
37.
go back to reference Harrell FE. Regression modeling strategies: with applications to linear models LR, and survival analysis. 1st ed. New York: Springer Science & Business Media; 2001.CrossRef Harrell FE. Regression modeling strategies: with applications to linear models LR, and survival analysis. 1st ed. New York: Springer Science & Business Media; 2001.CrossRef
38.
go back to reference Warren JL, Yabroff KR. Challenges and opportunities in measuring cancer recurrence in the United States. J Natl Cancer Inst. 2015;107(8):10–7.CrossRef Warren JL, Yabroff KR. Challenges and opportunities in measuring cancer recurrence in the United States. J Natl Cancer Inst. 2015;107(8):10–7.CrossRef
39.
go back to reference Jensen H, Vedsted P, Moller H. Consultation frequency in general practice before cancer diagnosis in relation to the patient's usual consultation pattern: a population-based study. Cancer Epidemiol. 2018;55:142–8.CrossRefPubMed Jensen H, Vedsted P, Moller H. Consultation frequency in general practice before cancer diagnosis in relation to the patient's usual consultation pattern: a population-based study. Cancer Epidemiol. 2018;55:142–8.CrossRefPubMed
40.
go back to reference Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 2012;13(4):353–65.CrossRefPubMed Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 2012;13(4):353–65.CrossRefPubMed
41.
go back to reference Heins M, Schellevis F, Rijken M, van der Hoek L, Korevaar J. Determinants of increased primary health care use in cancer survivors. J Clin Oncol. 2012;30(33):4155–60.CrossRefPubMed Heins M, Schellevis F, Rijken M, van der Hoek L, Korevaar J. Determinants of increased primary health care use in cancer survivors. J Clin Oncol. 2012;30(33):4155–60.CrossRefPubMed
42.
go back to reference Salani R, Backes FJ, Fung MFK, Holschneider CH, Parker LP, Bristow RE, et al. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011;204(6):466–78.CrossRefPubMed Salani R, Backes FJ, Fung MFK, Holschneider CH, Parker LP, Bristow RE, et al. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011;204(6):466–78.CrossRefPubMed
43.
go back to reference Nordin AJ. Mode of detection of recurrent gynecological malignancy: does routine follow-up delay diagnosis and treatment? Int J Gynecol Cancer. 2006;16(5):1746–8.CrossRefPubMed Nordin AJ. Mode of detection of recurrent gynecological malignancy: does routine follow-up delay diagnosis and treatment? Int J Gynecol Cancer. 2006;16(5):1746–8.CrossRefPubMed
44.
go back to reference Jeppesen MM, Mogensen O, Hansen DG, Iachina M, Korsholm M, Jensen PT. Detection of recurrence in early stage endometrial cancer – the role of symptoms and routine follow-up. Acta Oncol (Madr). 2017;56(2):262–9.CrossRef Jeppesen MM, Mogensen O, Hansen DG, Iachina M, Korsholm M, Jensen PT. Detection of recurrence in early stage endometrial cancer – the role of symptoms and routine follow-up. Acta Oncol (Madr). 2017;56(2):262–9.CrossRef
45.
go back to reference Francken AB, Shaw HM, Accortt NA, Soong S-J, Hoekstra HJ, Thompson JF. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol. 2007;14(6):1924–33.CrossRefPubMed Francken AB, Shaw HM, Accortt NA, Soong S-J, Hoekstra HJ, Thompson JF. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol. 2007;14(6):1924–33.CrossRefPubMed
46.
go back to reference Gilbert S, Reid KR, Lam MY, Petsikas D. Who should follow up lung cancer patients after operation? Ann Thorac Surg. 2000;69(6):1696–700.CrossRefPubMed Gilbert S, Reid KR, Lam MY, Petsikas D. Who should follow up lung cancer patients after operation? Ann Thorac Surg. 2000;69(6):1696–700.CrossRefPubMed
47.
go back to reference Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, et al. Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer. JAMA. 2018;319(20):2104–15.CrossRefPubMedPubMedCentral Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, et al. Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer. JAMA. 2018;319(20):2104–15.CrossRefPubMedPubMedCentral
48.
go back to reference Rasmussen LA, Jensen H, Virgilsen LF, Falborg AZ, Møller H, Vedsted P. Time from incident primary cancer until recurrence or second primary cancer: risk factors and impact in general practice. Eur J Cancer Care (Engl). 2019;28(5):e13123.CrossRef Rasmussen LA, Jensen H, Virgilsen LF, Falborg AZ, Møller H, Vedsted P. Time from incident primary cancer until recurrence or second primary cancer: risk factors and impact in general practice. Eur J Cancer Care (Engl). 2019;28(5):e13123.CrossRef
49.
go back to reference Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C. Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World J Gastrointest Oncol. 2014;6(5):104.CrossRefPubMedPubMedCentral Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C. Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World J Gastrointest Oncol. 2014;6(5):104.CrossRefPubMedPubMedCentral
50.
go back to reference Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106(7):1262–7.CrossRefPubMedPubMedCentral Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106(7):1262–7.CrossRefPubMedPubMedCentral
51.
go back to reference Grunfeld E, Earle CC. The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr. 2010;2010(40):25–30.CrossRefPubMedPubMedCentral Grunfeld E, Earle CC. The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr. 2010;2010(40):25–30.CrossRefPubMedPubMedCentral
52.
go back to reference Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24(6):848–55.CrossRefPubMed Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24(6):848–55.CrossRefPubMed
Metadata
Title
Healthcare utilisation in general practice and hospitals in the year preceding a diagnosis of cancer recurrence or second primary cancer: a population-based register study
Authors
Linda Aagaard Rasmussen
Henry Jensen
Line Flytkjær Virgilsen
Alina Zalounina Falborg
Henrik Møller
Peter Vedsted
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-4757-y

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue